CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

Current risk/benefit analyses indicate that shunt operations improve outcome compared to the spontaneous course of the disease. Conclusion: Normal pressure hydrocephalus should always enter into ...

which makes evaluation of "shunt-responsiveness" essential. First described by Hakim and Adams in 1965, idiopathic normal pressure hydrocephalus (INPH) is an enlargement of cerebral ventricles ...

I am an 84-year-old male in fairly good health for my age. I take 8-10 pills a day, including two over-the-counter ...

Normal pressure hydrocephalus (NPH ... A ventriculoperitoneal shunt was then inserted in the patient, and during a 1-year period his symptoms gradually improved. He recovered without any ...

The current treatment for NPH is shunt surgery ... Risk Variants Associated With Normal Pressure Hydrocephalus, Neurology ...

shunt in the treatment of elderly patients diagnosed with normal pressure hydrocephalus, also known as Hakim's Disease. The results of the STRIDE trial will serve as the basis for the company's ...

After a seemingly unending series of doctor and hospital visits, a doctor in Spokane diagnosed Alan with normal pressure hydrocephalus ... a neurosurgeon placed a shunt in Alan’s brain for ...